Health Care [ 3/12 ] | Biotechnology [ 26/74 ]
NASDAQ | Common Stock
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases.
Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is in Phase II clinical trial.
It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections.
The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020.
Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 7, 24 | -0.85 Decreased by -88.89% | -0.61 Decreased by -38.73% |
| Aug 8, 24 | -0.62 Decreased by -34.78% | -0.56 Decreased by -10.71% |
| May 9, 24 | -0.56 Increased by +30.00% | -0.53 Decreased by -5.66% |
| Mar 20, 24 | -0.60 Increased by +49.15% | -0.51 Decreased by -17.65% |
| Nov 9, 23 | -0.45 Increased by +50.55% | -0.53 Increased by +15.09% |
| Aug 10, 23 | -0.46 Increased by +16.36% | -0.69 Increased by +33.33% |
| May 11, 23 | -0.80 Decreased by -12.68% | -0.60 Decreased by -33.33% |
| Mar 28, 23 | -1.18 Decreased by -49.37% | -0.90 Decreased by -31.11% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 0.00 Decreased by N/A% | -46.63 M Decreased by -131.95% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -33.71 M Decreased by -67.19% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -28.38 M Increased by +4.61% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -25.66 M Increased by +20.91% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -20.10 M Increased by +16.63% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -20.16 M Decreased by -37.63% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -29.75 M Decreased by -73.50% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -32.44 M Decreased by -92.55% | Decreased by N/A% Decreased by N/A% |